Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared HolzUpside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.


 

Share This

Latest Mizuho News

Payment stocks down due policy uncertainty, says Mizuho’s Dan Dolev

Payment stocks down due policy uncertainty, says Mizuho’s Dan Dolev

January 13, 2026
Why Dutch Bros is a top stock pick for 2026, while Starbucks lags

Why Dutch Bros is a top stock pick for 2026, while Starbucks lags

December 23, 2025
Keeping current furniture tariff rates benefits home furnishings sector: Mizuho’s Bellinger

Keeping current furniture tariff rates benefits home furnishings sector: Mizuho’s Bellinger

January 2, 2026

Mizuho news from around the globe

back-to-top-blue